Although there is increasing knowledge on the immune cell types and states that participate in RA pathogenesis [3, 4], little is known on how the immune repertoire—the collection of T and B cell receptor chains—is shaped by disease or how it is associated with phenotypes of interest like the response to TNF inhibition (TNFi) therapy. Here, TNF is linked to rheumatoid arthritis.